RANKINGS
Lowest P/B — Healthcare
Price-to-Book ratio compares market value to book value. Lower may signal value.
63 companies with P/B Ratio data.
Ranked by P/B Ratio(63)
| # | Ticker | Name | Market Cap | P/B Ratio |
|---|---|---|---|---|
| 1 | APM | $570,062.5 | 0.0 | |
| 2 | CCM | $21M | 0.1 | |
| 3 | NIVF | $3M | 0.1 | |
| 4 | BON | $9M | 0.2 | |
| 5 | SCNI | $2M | 0.2 | |
| 6 | WOK | $6M | 0.3 | |
| 7 | LICN | $20M | 0.3 | |
| 8 | RGNT | $14M | 0.4 | |
| 9 | SNDL | $336M | 0.4 | |
| 10 | INTJ | $5M | 0.5 | |
| 11 | NNOX | $66M | 0.5 | |
| 12 | LITS | $34M | 0.6 | |
| 13 | PLSM | $17M | 0.7 | |
| 14 | ITOC | $6M | 0.7 | |
| 15 | AYTU | $24M | 0.7 | |
| 16 | AUNA | $378M | 0.9 | |
| 17 | ICCM | $8M | 0.9 | |
| 18 | CLGN | $5M | 0.9 | |
| 19 | MITQ | $6M | 1.2 | |
| 20 | INMD | $854M | 1.2 | |
| 21 | PLRZ | $27M | 1.3 | |
| 22 | BNR | $105M | 1.4 | |
| 23 | AVNS | $1.2B | 1.5 | |
| 24 | EVAX | $26M | 1.5 | |
| 25 | ALC | $34.9B | 1.6 | |
| 26 | ZTG | $11M | 1.6 | |
| 27 | BRTX | $5M | 1.7 | |
| 28 | MOLN | $178M | 1.8 | |
| 29 | GLXG | $6M | 1.8 | |
| 30 | GNTA | $48M | 1.9 | |
| 31 | BMRA | $6M | 2.0 | |
| 32 | BMGL | $9M | 2.0 | |
| 33 | PHG | $26.3B | 2.0 | |
| 34 | FOFO | $18M | 2.1 | |
| 35 | GIB | $15.4B | 2.2 | |
| 36 | SNN | $12.2B | 2.3 | |
| 37 | QGEN | $9.0B | 2.4 | |
| 38 | POCI | $48M | 2.4 | |
| 39 | IMTX | $1.4B | 2.5 | |
| 40 | CGEN | $261M | 2.5 | |
| 41 | MBAI | $9M | 2.6 | |
| 42 | STVN | $6.1B | 3.5 | |
| 43 | MDWD | $171M | 3.9 | |
| 44 | PDEX | $207M | 4.6 | |
| 45 | CLLS | $358M | 4.7 | |
| 46 | EGG | $79M | 5.0 | |
| 47 | VALN | $622M | 5.0 | |
| 48 | INNV | $1.5B | 5.8 | |
| 49 | ZJYL | $173M | 5.9 | |
| 50 | SPPL | $21M | 7.8 | |
| 51 | NVMI | $11.8B | 8.9 | |
| 52 | BWAY | $579M | 9.3 | |
| 53 | PYPD | $104M | 9.5 | |
| 54 | CAMT | $6.8B | 11.0 | |
| 55 | NNNN | $341M | 11.3 | |
| 56 | RYOJ | $71M | 11.6 | |
| 57 | JLHL | $141M | 14.4 | |
| 58 | ACCL | $39M | 17.7 | |
| 59 | DRTS | $1.4B | 17.8 | |
| 60 | CRDL | $241M | 18.4 | |
| 61 | SUPX | $423M | 21.3 | |
| 62 | ANAB | $1.7B | 133.1 | |
| 63 | RGC | $2.7B | 561.6 |
How to turn this ranking into valuation work
Start with the company page
Validate business quality, margins, capital structure, and the current valuation context before relying on a single multiple.
Then validate WACC
A cheap multiple does not guarantee a sensible discount rate. Check cost of capital before finalizing DCF assumptions.
Finish with DCF
Use the matching DCF page to test intrinsic value so multiples, discount rates, and cash-flow assumptions stay connected.
P/B Ratio Rankings in Other Sectors
Data updated daily · Source: SEC EDGAR, Polygon.io